Camp4 Therapeutics Corporation (CAMP)
NASDAQ: CAMP · Real-Time Price · USD
3.290
+0.130 (4.11%)
Oct 21, 2026, 4:00 PM EDT - Market closed
Camp4 Therapeutics Employees
Camp4 Therapeutics had 48 employees as of December 31, 2025. The number of employees decreased by 7 or 12.73% compared to the previous year. That makes Camp4 Therapeutics the 35,159th largest employer in the world and 4,709th in the United States.
Employees
48
Change (1Y)
-7
Growth (1Y)
-12.73%
Revenue / Employee
$87,833
Profits / Employee
-$2,234,250
Market Cap
206.46M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 48 | -7 | -12.73% |
| Dec 31, 2024 | 55 | -9 | -14.06% |
| Sep 30, 2024 | 53 | -11 | -17.19% |
| Jun 30, 2024 | 58 | - | - |
| Dec 31, 2023 | 64 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| MacroGenics | 293 |
| Protalix BioTherapeutics | 226 |
| ProQR Therapeutics | 187 |
| Sutro Biopharma | 128 |
| Compugen | 75 |
| InflaRx | 65 |
| PepGen | 57 |
| Pyxis Oncology | 56 |
CAMP News
- 1 day ago - Camp4 Therapeutics Transcript: Chardan's 10th Annual Healthcare Conference - Transcripts
- 6 days ago - Camp4 Therapeutics initiated with a Buy at Needham - TheFly
- 7 days ago - CAMP4 to Participate in Chardan's 10th Annual Healthcare Conference - GlobeNewsWire
- 16 days ago - Camp4 Therapeutics initiated with an Outperform at Oppenheimer - TheFly
- 22 days ago - Camp4 Therapeutics price target lowered to $6 from $6.50 at Chardan - TheFly
- 23 days ago - Camp4 Therapeutics Transcript: Analyst Day 2026 - Transcripts
- 23 days ago - Camp4 Therapeutics Slides: FY 2026 - Filings
- 5 weeks ago - CAMP4 Therapeutics Receives Authorization in the United Kingdom for Phase 1/2 Human Clinical Trial of CMP-002 in Patients with SYNGAP1-Related Disorder - GlobeNewsWire